Amrutanjan Health Care, a company in the Pharmaceuticals industry, reported revenue of ₹135 crore and net profit of ₹17 crore for the September 2026 quarter.
Amrutanjan Health Care (NSE: AMRUTANJAN) closed at ₹512.65 on 20 Nov 2026, down 26.9% over the past year. Its market capitalisation is ₹1,482 crore and it trades at 22.6 times earnings.
AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.